Zylox-Tonbridge Medical Technology Co., Ltd.

SEHK:2190 株式レポート

時価総額:HK$3.6b

Zylox-Tonbridge Medical Technology 将来の成長

Future 基準チェック /56

Zylox-Tonbridge Medical Technology is forecast to grow earnings and revenue by 69.8% and 23.8% per annum respectively. EPS is expected to grow by 69.9% per annum. Return on equity is forecast to be 6.6% in 3 years.

主要情報

69.8%

収益成長率

69.9%

EPS成長率

Medical Equipment 収益成長39.2%
収益成長率23.8%
将来の株主資本利益率6.6%
アナリストカバレッジ

Low

最終更新日02 Sep 2024

今後の成長に関する最新情報

Recent updates

Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Oct 02
Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Sep 27
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Apr 23
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Jan 18
Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

Sep 21
Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

Aug 03
There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jun 30
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

Mar 08
Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jan 19
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Jul 06
Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Jan 27
We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Oct 05
Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

業績と収益の成長予測

SEHK:2190 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20261,486309293274
12/31/20251,098188-641774
12/31/2024781101-146254
6/30/20246642623221N/A
3/31/2024596-27-35160N/A
12/31/2023528-79-9298N/A
9/30/2023470-101-17119N/A
6/30/2023411-124-250-60N/A
3/31/2023373-119-244-76N/A
12/31/2022334-114-237-91N/A
9/30/2022297-135-242-107N/A
6/30/2022259-155-247-122N/A
3/31/2022219-178-227-119N/A
12/31/2021178-200-206-116N/A
9/30/2021137-168-186-107N/A
6/30/202197-135-166-98N/A
3/31/202162-118-147-90N/A
12/31/202028-100-127-82N/A
12/31/20195-67-95-53N/A

アナリストによる今後の成長予測

収入対貯蓄率: 2190's forecast earnings growth (69.8% per year) is above the savings rate (2.3%).

収益対市場: 2190's earnings (69.8% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).

高成長収益: 2190's earnings are expected to grow significantly over the next 3 years.

収益対市場: 2190's revenue (23.8% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).

高い収益成長: 2190's revenue (23.8% per year) is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 2190's Return on Equity is forecast to be low in 3 years time (6.6%).


成長企業の発掘